YOLFTbeta
Kukje Pharma Co Ltd

Kukje Pharma Co Ltd

002720 · KO · Healthcare / Drug Manufacturers - Specialty & Generic

3,165.00KRW-40.00 (-1.25%)

Price History

Full chart

Market Stats

Previous Close3,205.00
Open3,245.00
Day Range3,165.00 – 3,265.00
52-Week Range2,810.00 – 5,440.00
Volume129.93K
Market Cap68.13B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.92%
Beta0.26
50-Day Avg3,299.70
200-Day Avg4,051.90

About

Kukje Pharma Co., Ltd. engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products. Its products include cephalosporins, quinolones, tetracycline, aminoglycosides, macrolides, other antibiotics, ophthalmic, antifungal and antiviral agents, ophthalmic agents, adrenal corticosteroids, CNS and osteoporotic agents, antihistamines, NSAIDS and other analgesics, gastrointestinal and cardiovascular agents, antidiabetics, genitourinary and respiratory agents, other ETC products, and other products. Kukje Pharma Co., Ltd. was founded in 1959 and is headquartered in Seongnam-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOTae-hoon Nam
  • Employees247
  • Headquarters96-8, Yatap-ro, Seongnam-si, South Korea, Korea
  • Websitehttps://www.kukjepharm.co.kr

Leadership

  • Tae-hoon NamCEO, President & Director
  • KiSeok YoonDeputy Director of Finance Department
  • Sung-Gyu KimCOO & Director · b. 1964
  • Mr. Young Kwan KimCTO, MD & Director
  • Hyunsuk ChungSenior Director of Human Resources & Administration Department
  • GyeongGu JeongSenior Director of Public Affairs Team
  • DongSeon KimDeputy Director of Marketing Department
  • OhYong KwonDeputy MD of Sales Division
  • BoSuk OhDeputy MD & CSO

Financials

Income Statement

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue104.86B126.77B120.46B122.43B117.64B120.68B123.31B107.68B111.12B130.39B119.75B126.58B135.37B156.46B175.50B
Growth (%)-+20.90%-4.98%+1.63%-3.91%+2.59%+2.18%-12.67%+3.20%+17.34%-8.17%+5.71%+6.94%+15.58%+12.16%
Cost of Revenue57.32B78.75B69.23B72.09B64.86B66.90B71.84B58.87B58.14B65.59B65.28B63.33B68.15B73.97B81.85B
Gross Profit--47.77B47.17B52.78B53.78B51.47B48.81B52.99B64.80B54.47B63.25B67.22B82.50B93.64B
Gross Margin--39.66%38.53%44.86%44.56%41.74%45.33%47.68%49.70%45.49%49.97%49.66%52.73%53.36%
Operating Expense--46.73B48.59B50.68B49.81B48.91B45.52B47.41B58.76B56.15B57.98B69.21B75.79B87.46B
Operating Income2.60B-1.05B-1.42B2.10B3.97B2.56B3.29B5.57B6.04B-1.68B5.27B-1.99B6.70B6.18B
Operating Margin2.48%-0.87%-1.16%1.78%3.29%2.08%3.05%5.01%4.63%-1.40%4.17%-1.47%4.28%3.52%
EBITDA------5.58B6.47B4.24B9.87B4.01B10.23B-1.04B11.02B10.58B
EBITDA Margin------4.53%6.01%3.81%7.57%3.34%8.08%-0.77%7.04%6.03%
Net Income927.81M-1.67B-6.93B-5.94B773.06M1.09B2.19B-4.76B2.20B-1.56B3.56B-8.42B5.21B5.70B
Net Income Margin0.88%-1.39%-5.66%-5.05%0.64%0.89%2.04%-4.28%1.69%-1.30%2.81%-6.22%3.33%3.25%
R&D--816.58M1.53B1.07B1.33B3.29B3.59B2.60B3.04B2.77B1.97B2.65B1.81B3.66B
R&D as % of Total Revenue--0.68%1.25%0.91%1.10%2.67%3.34%2.34%2.33%2.32%1.55%1.95%1.16%2.09%
Interest Expense0000000900.56M862.99M650.13M696.43M1.00B1.44B1.21B908.41M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.84%0.78%0.50%0.58%0.79%1.06%0.77%0.52%

Balance Sheet

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets141.61B114.92B117.43B117.51B136.64B129.46B131.65B126.23B134.59B145.63B139.78B136.59B163.26B165.55B182.28B
Total Liabilities66.82B59.57B59.10B66.66B68.18B61.94B63.87B57.54B73.64B75.13B71.20B62.51B78.31B76.00B84.57B
Total Equity74.44B54.99B58.29B50.80B68.26B67.50B67.74B68.67B60.93B70.48B68.57B74.07B84.94B89.54B97.69B
Cash11.05B8.89B898.71M604.64M485.91M6.39B2.53B3.66B7.45B4.01B7.87B5.54B10.59B8.68B10.70B
Net Debt------31.97B25.34B27.61B31.99B26.13B21.46B19.41B20.32B19.30B

Cash Flow

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow17.39B1.58B-4.60B-61.11M-5.08B16.10B786.10M13.25B3.60B5.10B9.60B6.50B3.58B3.94B5.84B
Investing Cash Flow---3.42B-633.79M-1.75B-4.94B-5.54B-6.43B-5.13B-8.98B-3.38B-1.35B---
Financing Cash Flow--24.70M400.82M6.71B-5.29B892.79M-5.68B5.33B621.95M-2.43B-7.47B---
Capital Expenditure1.00B1.59B1.68B2.38B1.18B2.69B2.61B3.03B5.89B11.60B1.89B1.26B1.05B2.99B3.87B
Free Cash Flow-------3.32B9.80B-2.28B-6.50B7.64B5.23B2.53B945.21M1.97B
Dividends Paid392.30M278.49M143.42M143.42M147.72M157.86M157.86M165.13M515.12M-----610.88M
FCF to OCF-------422.76%73.94%-63.35%-127.44%79.57%80.37%70.75%23.99%33.70%
Dividend Paid to FCF-------4.75%1.69%-22.56%-----31.06%

Earnings

Report DateMar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Jan 27, 2014Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Mar 29, 2024Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate--------------------------------------------------------------
EPS Actual15.4910.707.8531.68-115.13-368.62-47.13-416.2317.5427.95-49.38113.45-44.592.9659.85-366.5835.0363.06-36.00-346.2931.87-3.70-9.1619.6438.409.9542.73-35.3248.74-21.8062.2418.96102.04-350.0741.21-26.04241.7814.8033.02-180.9342.066.2539.79-165.04111.2258.6071.91-60.8743.19-309.37-128.08-19.22135.0429.3456.5334.7691.04130.7094.00-34.57101.5378.93
Surprise--------------------------------------------------------------
Timing---------------------------------------------------Pre-market----------

Key Statistics & Ratios

Market Cap68.13B
Enterprise Value84.12B
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales0.38
Price / Book0.69
Revenue (TTM)181.27B
Gross Profit (TTM)97.26B
EBITDA7.84B
Profit Margin2.76%
Operating Margin4.42%
Return on Equity5.18%
Return on Assets1.57%
Shares Outstanding21.16M
Shares Float13.16M
Beta0.26
Dividend Yield0.92%
Dividend Rate30.00
Payout Ratio12.51%

Dividends

20261×
30.00Mar 12, 2026
20251×
30.00Mar 13, 2025
20181×
25.92Dec 27, 2018
20171×
8.47Dec 27, 2017
20161×
7.76Dec 28, 2016
20141×
7.39Dec 29, 2014
20131×
7.39Dec 27, 2013
20112×
14.34Dec 28, 201119.89Mar 30, 2011
20101×
20.89Mar 30, 2010
20091×
13.14Mar 30, 2009
20081×
6.26Mar 28, 2008
20071×
60.15Mar 29, 2007
20061×
60.15Mar 30, 2006
20051×
60.15Mar 30, 2005
20041×
48.12Mar 30, 2004
20031×
42.10Mar 28, 2003
20021×
36.09Mar 28, 2002
20011×
36.09Mar 29, 2001
20001×
11.57Mar 30, 2000
19991×
5.61Mar 30, 1999
19981×
5.45Mar 30, 1998
19961×
5.34Mar 30, 1996

Stock Splits

  • Mar 17, 20231.05:1
  • Mar 18, 20221.05:1
  • Mar 2, 20211.05:1
  • Dec 27, 20181.02:1
  • Dec 27, 20171.04:1
  • Dec 28, 20161.05:1
  • Dec 29, 20141.05:1
  • Dec 27, 20131.03:1
  • Dec 28, 20111.03:1
  • Mar 30, 20111.05:1
  • Mar 30, 20091.05:1
  • Mar 28, 20081.04:1
  • Jun 28, 20065:1